Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
Article in Journal of Clinical Oncology (February 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Journal of Clinical Oncology (February 2024)
Article in Metabolites (September 2023)
Article in Cells (September 2023)